Supernus Pharmaceuticals
SUPN
#4205
Rank
A$3.94 B
Marketcap
A$68.01
Share price
0.04%
Change (1 day)
32.85%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: A$3.94 Billion

As of May 2026 Supernus Pharmaceuticals has a market cap of A$3.94 Billion. This makes Supernus Pharmaceuticals the world's 4205th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.94 B-10.59%
2025A$4.41 B33.75%
2024A$3.30 B42.23%
2023A$2.32 B-18.1%
2022A$2.83 B32.47%
2021A$2.13 B23.65%
2020A$1.72 B-2.8%
2019A$1.77 B-27.86%
2018A$2.46 B-5.72%
2017A$2.61 B50.79%
2016A$1.73 B91.94%
2015A$0.90 B107.44%
2014A$0.43 B28.95%
2013A$0.33 B59.97%
2012A$0.21 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

A$3.94 Billion
by Nasdaq info icon info icon
A$3.94 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$779.79 B 19,655.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$217.73 B 5,416.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.272 T 32,138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$167.45 B 4,142.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
A$2.11 B-46.54%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$33.98 B 761.09%๐Ÿ‡บ๐Ÿ‡ธ USA